HYPERHIDROSIS TREATMENT MARKET ANALYSIS
Global Hyperhidrosis Treatment Market Regional Analysis
North America is expected to hold a dominant position in the global hyperhidrosis market due to presence of key players such as Brickell Biotech Inc., Dermira Inc., and others. These key players are focused on adapting growth strategies such as mergers, acquisitions, partnership, collaboration, etc. For instance, in June 2019, Brickell Biotech, Inc., a clinical stage pharmaceutical company merged with Vical Inc., a biopharmaceutical company. The aim of the merger was for developing novel approaches to treat hyperhidrosis and other dermatological disorders.
Furthermore, Asia Pacific is expected to witness significant growth in the global hyperhidrosis treatment market, owing to increasing prevalence of hyperhidrosis in the region. According to the Department of Dermatology, Government Medical College (India) data of 2018, around 320 cases (out of 10,000) were diagnosed with hyperhidrosis. Hence higher prevalence of hyperhidrosis may lead to increase in demand for the treatment, which is expected to support the global hyperhidrosis treatment market growth.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
